Free Cash Flow for Bio-Techne (TECH)
Free Cash Flow for Bio-Techne (TECH): headline value $223.02M · YoY +8.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
TECH
Currently viewingFree Cash FlowSwitch metric
Latest period
$223.02M
YoY change
+8.7%
5Y CAGR
+10.8%
Peak year (2021)
$307.86M
Latest annual
$256.55M
Free Cash Flow history chart for Bio-Techne (TECH) from 1990 to 2025
Free Cash Flow history table for Bio-Techne (TECH) from 1990 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $256.55M | +8.7% | ||
| 2024 | $236.10M | +9.2% | ||
| 2023 | $216.15M | -22.9% | ||
| 2022 | $280.36M | -8.9% | ||
| 2021 | $307.86M | +100.6% | ||
| 2020 | $153.47M | -1.8% | ||
| 2019 | $156.21M | +4.5% | ||
| 2018 | $149.43M | +16.5% | ||
| 2017 | $128.27M | +1.0% | ||
| 2016 | $126.97M | +6.3% | ||
| 2015 | $119.45M | -2.8% | ||
| 2014 | $122.94M | +21.6% | ||
| 2013 | $101.11M | -16.3% | ||
| 2012 | $120.73M | -2.3% | ||
| 2011 | $123.56M | +15.9% | ||
| 2010 | $106.62M | +1.8% | ||
| 2009 | $104.77M | +5.9% | ||
| 2008 | $98.95M | +20.0% | ||
| 2007 | $82.43M | +1.8% | ||
| 2006 | $80.99M | +28.5% | ||
| 2005 | $63.02M | +1.9% | ||
| 2004 | $61.84M | +59.0% | ||
| 2003 | $38.90M | +621.5% | ||
| 2002 | $5.39M | -86.4% | ||
| 2001 | $39.56M | +372.5% | ||
| 2000 | $8.37M | -480.5% | ||
| 1999 | -$2.20M | -112.7% | ||
| 1998 | $17.30M | +108.4% | ||
| 1997 | $8.30M | +144.1% | ||
| 1996 | $3.40M | -43.3% | ||
| 1995 | $6.00M | +20.0% | ||
| 1994 | $5.00M | +163.2% | ||
| 1993 | $1.90M | -42.4% | ||
| 1992 | $3.30M | +266.7% | ||
| 1991 | $900,000 | +28.6% | ||
| 1990 | $700,000 | — |
Free Cash Flow values are taken from Bio-Techne's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Bio-Techne (TECH) reported free cash flow of $256.55M – grew 8.7% year-over-year.
Bio-Techne free cash flow compound annual growth for the 2020–2025 (5 years) window is +10.8%, sustaining 2 straight years of year-over-year growth.
Bio-Techne free cash flow peaked at $307.86M in 2021; the latest annual figure is $256.55M in 2025 (16.7% below peak).
2021 marks the peak free cash flow at $307.86M, with the historical low of -$2.20M recorded in 1999.
Within Healthcare, Bio-Techne (TECH) ranks 9th among 8 peers we track. The peer median for free cash flow is $14.22B.
Bio-Techne Free Cash Flow by Year
Bio-Techne Free Cash Flow 2025: $256.55M
Bio-Techne free cash flow in 2025 was $256.55M, grew 8.7% from 2024.
Bio-Techne Free Cash Flow 2024: $236.10M
Bio-Techne free cash flow in 2024 was $236.10M, grew 9.2% from 2023.
Bio-Techne Free Cash Flow 2023: $216.15M
Bio-Techne free cash flow in 2023 was $216.15M, declined 22.9% below 2022.
Bio-Techne Free Cash Flow 2022: $280.36M
Bio-Techne free cash flow in 2022 was $280.36M, declined 8.9% below 2021.
Bio-Techne Free Cash Flow 2021: $307.86M
Bio-Techne free cash flow in 2021 was $307.86M.
See more financial history for Bio-Techne (TECH).
Sector peers — Free Cash Flow
Companies in the same sector as Bio-Techne, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is Bio-Techne's free cash flow?
Latest reported free cash flow for Bio-Techne (TECH) is $223.02M (period ending December 31, 2025).
How has Bio-Techne free cash flow changed year-over-year?
Bio-Techne (TECH) free cash flow changed +8.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Bio-Techne free cash flow?
Bio-Techne (TECH) free cash flow compound annual growth rate is +10.8% over the most recent 5 years available.
When did Bio-Techne free cash flow hit its highest annual value?
Bio-Techne free cash flow reached its highest annual value of $307.86M in 2021.
What was Bio-Techne free cash flow in 2024?
Bio-Techne (TECH) free cash flow in 2024 was $236.10M.
What was Bio-Techne free cash flow in 2025?
Bio-Techne (TECH) free cash flow in 2025 was $256.55M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
TECH Overview
Company profile, financial tools, and key metrics
TECH Revenue Counter
Earns $38.55 every second. See per minute, hour, and day.
TECH Earnings Counter
Earns $2.57 per second net profit. See per minute, hour, and day.
TECH Economic Scale
Exceeds Samoa's GDP. Compare with world economies.
TECH What If Invested
What if you had invested $1,000? See historical returns from any date.
TECH How It Makes Money
Discover visual breakdown of $1.22B in revenue — where it comes from and where it goes.
TECH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TECH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TECH Daily Price Character
Balanced · 45.3% historical win rate (green days). Streaks & record days.
TECH Buybacks
2.18% TTM buyback yield. Shareholder yield & SBC comparison.
TECH Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
TECH Dividend Profile
Yield: 0.62%. Safety: 5/8. See full history.
TECH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TECH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.